Metabiomics

Opioids can be effective for pain relief when used as prescribed, but they also carry the risk of dependence, misuse, and addiction, with factors like genetics playing a role. AvertD, an FDA-approved test, uses DNA from buccal swabs to determine whether they have a specific set of genetic variants that may be associated with an elevated genetic risk of developing opioid use disorder (OUD). AvertD can be a crucial part of assessing a patient’s risk for OUD within a comprehensive clinical evaluation.

Learn more about AvertD by SOLVD Health: https://avertdtest.com/

Metabiomics is hiring a bioinformatics engineer. Join our team in San Diego to work on a , and driven test to detect and prevent colon cancer!

Metabiomics hiring Software Engineer, Bioinformatics in California, United States | LinkedIn Posted 2:16:43 AM. At Metabiomics, a Joint Venture with SOLVD Health (formerly Prescient Medicine), we’re focused on…See this and similar jobs on LinkedIn.

Metabiomics is hiring a Director of Assay Development to accelerate the development of our microbiome diagnostics platform and NGS lab. https://buff.ly/333zYTI

New Recommendations for How Often to Repeat Colonoscopy Following Polypectomy

New Recommendations for How Often to Repeat Colonoscopy Following Polypectomy A new multisociety guideline was recently released suggesting that for many patients, the interval between colonoscopies following polyp resection is less than previously recommended. Cecelia Zhang, MD, Duke University, and Maylyn Martinez, MD, University of Chicago, discuss the new guideline.

Gamers are helping map the human gut Microbiome! AI+Gamer-driven analytics.

Borderlands 3 is using its millions of gamers to help map the human gut microbiome Gearbox Studios CEO Randy Pitchford and videogame science company MMOS cofounder Attila Szantner discuss the design and deployment decisions that drew 1.6 million players to their gene sequencing alignment puzzle game, and how "citizen science" games can help advance data-driven research.

The majority of colon cancers can be prevented with screening programs that deploy colonoscopy and non-invasive tests. There's still a need for more sensitive stool tests, which is exactly what Metabiomics is focused on.

As many avoid colonoscopies, doctors say non-invasive tests could help prevent colorectal cancer Less may be more when it comes to colonoscopies. While it’s a highly effective screening tool, the invasive colonoscopy is uncomfortable to prepare for. That may be why so many take a pass on it.&n…

Prescient Metabiomics and the Harvard Chan Microbiome in Public Health Center Collaborate to Advance Research in Colon Cancer Screening - Metabiomics Prescient Metabiomics announced today a collaboration with the Harvard microbiome center to study microbial biomarkers for detecting colon cancer.

https://buff.ly/35HvQcf "By the end of this decade, I predict that these early detection tests will impact cancer survival to a greater extent than therapies."

Council Post: The Precision Medicine Revolution Will Be Driven By Diagnostic Technologies In the future, diagnostic technologies will matter just as much as therapeutics and significantly improve the deployment of healthcare spending.

At the intersection of the gut microbiome, NGS sequencing, and AI-Driven analytics emerges a breakthrough test for colon cancer prevention. and announce new collaboration.

Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test - Metabiomics CARLSBAD, Calif., Dec. 17, 2019 /PRNewswire/ — Prescient Metabiomics, a subsidiary of Prescient Medicine Holdings, Inc., and CoreBiome, a wholly owned subsidiary of OraSure Technologies, Inc., announced today a collaboration to develop a new test called LifeKit® Prevent, which may represent a mic...

Prescient Metabiomics LifeKit Prevent Colon Cancer Test has been granted a Breakthrough Designation by the FDA.

FDA Grants Breakthrough Designation to the Prescient Metabiomics LifeKit® Prevent Test for the Early Detection of Colon Polyps and Colon Cancer - Metabiomics Prescient Metabiomics receives FDA Breakthrough designation for metagenomics colon cancer test, LifeKit Prevent.